Answers are grounded in this paper and cite their sources.
Urolithiasis is a common urinary disorder characterized by the formation of stones in the urinary tract, particularly calcium oxalate stones. It is associated with urinary supersaturation, crystal nucleation, growth, aggregation, oxidative stress, and renal tissue injury. Although several treatment approaches are available, recurrence and adverse effects associated with conventional therapies have increased interest in exploring natural compounds with potential anti-lithiatic properties. Usnic acid, a naturally occurring dibenzofuran derivative obtained from lichens, has demonstrated various pharmacological activities, including antioxidant, anti-inflammatory, and antimicrobial effects. These properties provide a scientific basis for investigating its possible protective role in experimental urolithiasis. The present review focuses on the potential anti-lithiatic activity of usnic acid, its pharmacological properties, possible mechanisms of action, and its relevance in calcium oxalate stone formation. Particular attention is given to the inhibition of crystal formation and deposition, reduction of oxidative stress, and protection against renal epithelial damage. Male Wistar rats with urolithiasis induced by ethylene glycol (0.75% v/v) and ammonium chloride (1% w/v) can be used for experimental evaluation. Urinary, serum biochemical, and histopathological parameters can be assessed to determine its protective effects. However, further investigations are necessary to establish its efficacy, safety, and therapeutic potential
No takes yet. Share an insight, caveat, or question.
Pavani et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: